NFE2L2 and chronic myelogenous leukemia, BCR-ABL1 positive: To determine if any of these sites were important in the down-regulation of Nrf2 by Wogonin in resistant CML cells, we created site-directed mutants of the human Nrf2 promoter, which removed one or the other of the κB sites.